title: Selective impairment of neuroendocrine and hemodynamic responses to a mu-opioid peptide in aged rats.
abstract: The objective of this study was to determine if there are age-related alterations in hemodynamic and/or neuroendocrine responses to the mu-opioid receptor agonist, [D-Ala2,MePhe4,Gly(ol)5] enkephalin (DAMGO), or corticotropin releasing hormone (CRH) administered centrally. To this end, DAMGO (1-3 nmoles) or CRH (1 nmole) was injected intracerebroventricularly (icv) to freely moving young (6-8 month) and aged (24-26 month) Fischer 344 male rats. Blood pressure, heart rate (HR), and plasma concentrations of norepinephrine (NE), epinephrine (EPI), adrenocorticotropin (ACTH), and prolactin (PRL) were measured over time. Under basal conditions, NE levels were higher and blood pressures were lower in aged rats, whereas there were no significant differences in EPI, ACTH, or PRL levels. The stimulatory effect of DAMGO on blood pressure, HR, and plasma EPI and ACTH was attenuated, but the PRL response was enhanced in aged cohorts. In contrast, there were no age-related differences in the NE responses to DAMGO or CRH nor in CRH-induced increases in EPI or ACTH. The sympathoadrenal and hemodynamic effects of DAMGO were blocked by naloxone in both age groups. These results indicate that alterations in mu-opioid function with age are specific for the opioid system and do not reflect a generalized decline in central regulation of neuroendocrine and cardiovascular function.
authors.affiliation: Department of Neurology, University of Michigan, Ann Arbor.
authors.forename: J A
authors.initials: JA
authors.lastname: Kiritsy-Roy
authors.forename: J B
authors.initials: JB
authors.lastname: Halter
authors.forename: M J
authors.initials: MJ
authors.lastname: Smith
authors.forename: L C
authors.initials: LC
authors.lastname: Terry
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000375:Aging / Q000502:physiology*; D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004745:Enkephalins / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004837:Epinephrine / Q000097:blood; D006439:Hemodynamics / Q000187:drug effects*; D006728:Hormones / Q000097:blood*; D009270:Naloxone / Q000494:pharmacology; D009638:Norepinephrine / Q000097:blood; D011388:Prolactin / Q000097:blood; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D004745:Enkephalins; D006728:Hormones; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D009270:Naloxone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D003346:Corticotropin-Releasing Hormone; D009638:Norepinephrine; D004837:Epinephrine